Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A 42-year-old family nurse practitioner (FNP) is beginning independent
practice in a state that grants full practice authority. A pharmaceutical
representative offers complimentary meals and educational materials
while discussing a newly approved antihypertensive medication. Which
action best reflects the advanced practice nurse's professional
responsibility as a prescriber?
A. Accept all promotional information because FDA approval ensures
unbiased education.
B. Base prescribing decisions primarily on peer-reviewed evidence,
clinical guidelines, and patient-specific factors while recognizing
potential conflicts of interest.
C. Routinely prescribe the promoted medication to gain experience
with new therapies.
D. Avoid prescribing any newly approved medication for at least 10
years.
Correct Answer: B
Rationale: Advanced practice prescribers should critically evaluate
medication information using evidence-based literature, current clinical
guidelines, and individualized patient assessment. Pharmaceutical
marketing may introduce bias and should not be the primary source for
prescribing decisions. FDA approval confirms safety and efficacy
standards but does not eliminate promotional bias. Automatically
prescribing or completely avoiding new medications are both
inappropriate approaches.
,Question 2
An APRN is evaluating a 70-year-old patient with hypertension, chronic
kidney disease, diabetes mellitus, and osteoarthritis. The patient takes
medications prescribed by three specialists. What is the APRN's highest
prescribing priority before initiating another medication?
A. Prescribe the medication with the lowest acquisition cost.
B. Perform comprehensive medication reconciliation, including
prescription drugs, over-the-counter medications, and herbal
supplements.
C. Assume specialists have already evaluated all medication
interactions.
D. Discontinue one chronic medication to minimize pill burden without
further assessment.
Correct Answer: B
Rationale: Medication reconciliation is essential before prescribing. It
identifies therapeutic duplication, drug-drug interactions, inappropriate
medications, adherence issues, and potential adverse effects. Cost
considerations are important but secondary to patient safety. Assuming
medication review has already occurred or discontinuing medications
without assessment increases patient risk.
Question 3
An APRN prescribes an antibiotic for community-acquired pneumonia.
Two days later, the patient reports a generalized rash and mild facial
swelling. What is the APRN's priority action?
, A. Continue therapy because mild allergic reactions often resolve
spontaneously.
B. Instruct the patient to double the dose.
C. Immediately evaluate the patient for possible drug hypersensitivity
and determine whether the medication should be discontinued.
D. Recommend taking the medication with food.
Correct Answer: C
Rationale: Early recognition of medication-related hypersensitivity is a
critical prescribing responsibility. Facial swelling may indicate
progression toward a serious allergic reaction requiring prompt
evaluation. Continuing therapy or increasing the dose may worsen the
reaction. Taking medication with food does not address allergic
manifestations.
Question 4
A patient asks why the APRN selected a generic medication rather than
the advertised brand-name product. Which response is most
appropriate?
A. Generic medications are always clinically superior.
B. Brand-name medications should only be prescribed after generic
therapy fails.
C. FDA-approved generic medications are expected to provide
comparable therapeutic outcomes while often reducing patient cost.
D. Insurance companies prohibit prescribing brand-name medications.
Correct Answer: C
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A 42-year-old family nurse practitioner (FNP) is beginning independent
practice in a state that grants full practice authority. A pharmaceutical
representative offers complimentary meals and educational materials
while discussing a newly approved antihypertensive medication. Which
action best reflects the advanced practice nurse's professional
responsibility as a prescriber?
A. Accept all promotional information because FDA approval ensures
unbiased education.
B. Base prescribing decisions primarily on peer-reviewed evidence,
clinical guidelines, and patient-specific factors while recognizing
potential conflicts of interest.
C. Routinely prescribe the promoted medication to gain experience
with new therapies.
D. Avoid prescribing any newly approved medication for at least 10
years.
Correct Answer: B
Rationale: Advanced practice prescribers should critically evaluate
medication information using evidence-based literature, current clinical
guidelines, and individualized patient assessment. Pharmaceutical
marketing may introduce bias and should not be the primary source for
prescribing decisions. FDA approval confirms safety and efficacy
standards but does not eliminate promotional bias. Automatically
prescribing or completely avoiding new medications are both
inappropriate approaches.
,Question 2
An APRN is evaluating a 70-year-old patient with hypertension, chronic
kidney disease, diabetes mellitus, and osteoarthritis. The patient takes
medications prescribed by three specialists. What is the APRN's highest
prescribing priority before initiating another medication?
A. Prescribe the medication with the lowest acquisition cost.
B. Perform comprehensive medication reconciliation, including
prescription drugs, over-the-counter medications, and herbal
supplements.
C. Assume specialists have already evaluated all medication
interactions.
D. Discontinue one chronic medication to minimize pill burden without
further assessment.
Correct Answer: B
Rationale: Medication reconciliation is essential before prescribing. It
identifies therapeutic duplication, drug-drug interactions, inappropriate
medications, adherence issues, and potential adverse effects. Cost
considerations are important but secondary to patient safety. Assuming
medication review has already occurred or discontinuing medications
without assessment increases patient risk.
Question 3
An APRN prescribes an antibiotic for community-acquired pneumonia.
Two days later, the patient reports a generalized rash and mild facial
swelling. What is the APRN's priority action?
, A. Continue therapy because mild allergic reactions often resolve
spontaneously.
B. Instruct the patient to double the dose.
C. Immediately evaluate the patient for possible drug hypersensitivity
and determine whether the medication should be discontinued.
D. Recommend taking the medication with food.
Correct Answer: C
Rationale: Early recognition of medication-related hypersensitivity is a
critical prescribing responsibility. Facial swelling may indicate
progression toward a serious allergic reaction requiring prompt
evaluation. Continuing therapy or increasing the dose may worsen the
reaction. Taking medication with food does not address allergic
manifestations.
Question 4
A patient asks why the APRN selected a generic medication rather than
the advertised brand-name product. Which response is most
appropriate?
A. Generic medications are always clinically superior.
B. Brand-name medications should only be prescribed after generic
therapy fails.
C. FDA-approved generic medications are expected to provide
comparable therapeutic outcomes while often reducing patient cost.
D. Insurance companies prohibit prescribing brand-name medications.
Correct Answer: C
